Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 3,802 shares at $1.46 ($6K) on 2022-08-02, disclosed to the SEC on 2022-08-03.
Open-market sale of $6k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.46 | 1,702 | $2K | 44.8% |
| 2 | $1.46 | 2,100 | $3K | 55.2% |
| Total | $1.46 avg | 3,802 | $6K | 100% |
| Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-03-03 | $20K | — | Filing → |